Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.48 |
| ▸ | GABRG2 | P18507 | 3/20 | 0.48 |
| ▸ | GABRB3 | P28472 | 3/20 | 0.48 |
| ▸ | GABRA5 | P31644 | 3/20 | 0.48 |
| ▸ | GABRA3 | P34903 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 5/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | AKT1 | P31749 | 1/20 | 0.41 |
| ▸ | AKT2 | P31751 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | METAP2 | P50579 | 1/20 | 0.40 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | SMARCA2 | P51531 | 1/20 | 0.38 |
| ▸ | SMARCA4 | P51532 | 1/20 | 0.38 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29429231 | 1.00 | GABRA1 (0.48) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| Bromide SCHEMBL28568919 | 0.98 | GABRA1 (0.47) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| Benzamide SCHEMBL28855712 | 0.82 | CYP2C19 (0.52) | RAB9ANPC1ALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL30950412 | 0.76 | — | — | |
| SCHEMBL29584431 | 0.76 | GABRG2 (0.51) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL12806833 | 0.72 | GABRA1 (0.54) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL151034 | 0.71 | GABRA1 (0.43) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL21938127 | 0.71 | GABRA1 (0.54) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL29516145 | 0.71 | GABRA1 (0.43) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL23888753 | 0.71 | KDM4E (0.58) | RAB9ANPC1ALDH1A1METAP2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731603-A1 | LOW TEMPERATURE REACTIVE ARYL AZIDES | SuSoS AG (CH) | 2026-04-29 | — | — | EP | claimed |
| WO-2024261308-A1 | LOW TEMPERATURE REACTIVE ARYL AZIDES | SUSOS AG (CH) | 2024-12-26 | — | — | WO | claimed |
| US-20190189933-A1 | ORGANIC SEMICONDUCTOR MATERIAL FOR ELECTRON TRANSPORT | DAEGU GYEONGBUK INSTITUTE OF SCIENCE & TECHNOLOGY (KR) | 2019-06-20 | — | — | US | claimed |
| EP-4731603-A1 | LOW TEMPERATURE REACTIVE ARYL AZIDES | SuSoS AG (CH) | 2026-04-29 | — | — | EP | disclosed |
| US-20260021196-A1 | HOMOGENEOUS ANTIBODY-CONJUGATES WITH HIGH PAYLOAD LOADING | SYNAFFIX BV (NL) | 2026-01-22 | — | — | US | disclosed |
| EP-4658318-A1 | HOMOGENEOUS ANTIBODY-CONJUGATES WITH HIGH PAYLOAD LOADING | Synaffix B.V. (NL) | 2025-12-10 | — | — | EP | disclosed |
| WO-2024261308-A1 | LOW TEMPERATURE REACTIVE ARYL AZIDES | SUSOS AG (CH) | 2024-12-26 | — | — | WO | disclosed |
| CN-118955522-A | Naphthalene radical hybridization molecular tube and preparation method and application thereof | 南方科技大学 | 2024-11-15 | — | — | CN | disclosed |
| WO-2024187006-A1 | BIOORTHOGONAL ACTIVATION OF PROTAC PRODRUGS | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2024-09-12 | — | — | WO | disclosed |
| WO-2024160926-A1 | HOMOGENEOUS ANTIBODY-CONJUGATES WITH HIGH PAYLOAD LOADING | SYNAFFIX B.V. (NL) | 2024-08-08 | — | — | WO | disclosed |
| EP-4410313-A1 | HOMOGENEOUS ANTIBODY-CONJUGATES WITH HIGH PAYLOAD LOADING | Synaffix B.V. (NL) | 2024-08-07 | — | — | EP | disclosed |
| US-9293768-B2 | Battery electrode, method of producing the same, nonaqueous electrolyte battery, battery pack, and active material | KABUSHIKI KAISHA TOSHIBA (JP) | 2016-03-22 | — | — | US | disclosed |
| EP-2986603-A1 | RADIOLABELED GNRH ANTAGONISTS AS PET IMAGING AGENTS | Oslo Universitetssykehus HF (NO) | 2016-02-24 | — | — | EP | disclosed |
| US-20150279654-A1 | TREATING SOLUTION FOR ELECTRONIC PARTS, AND PROCESS FOR PRODUCING ELECTRONIC PARTS | FINE POLYMERS CORPORATION (JP) | 2015-10-01 | — | — | US | disclosed |
| US-20150279654-A1 | TREATING SOLUTION FOR ELECTRONIC PARTS, AND PROCESS FOR PRODUCING ELECTRONIC PARTS | FINE POLYMERS CORPORATION (JP) | 2015-10-01 | — | — | US | disclosed |
| US-20150279654-A1 | TREATING SOLUTION FOR ELECTRONIC PARTS, AND PROCESS FOR PRODUCING ELECTRONIC PARTS | FINE POLYMERS CORPORATION (JP) | 2015-10-01 | — | — | US | disclosed |
| WO-2014184682-A9 | RADIOLABELED GNRH ANTAGONISTS AS PET IMAGING AGENTS | OSLO UNIVERSITETSSYKEHUS HF (NO) | 2015-01-29 | — | — | WO | disclosed |
| WO-2014184682-A1 | RADIOLABELED GNRH ANTAGONISTS AS PET IMAGING AGENTS | OSLO UNIVERSITETSSYKEHUS HF (NO) | 2014-11-20 | — | — | WO | disclosed |
| US-20120058395-A1 | BATTERY ELECTRODE, METHOD OF PRODUCING THE SAME, NONAQUEOUS ELECTROLYTE BATTERY, BATTERY PACK, AND ACTIVE MATERIAL | KABUSHIKI KAISHA TOSHIBA (JP) | 2012-03-08 | — | — | US | disclosed |
| US-3863010-A | Compositions of matter and method of use of phenyl and substituted phenyl tetrazines | AMERICAN CYANAMID CO | 1975-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260021196-A1 | HOMOGENEOUS ANTIBODY-CONJUGATES WITH HIGH PAYLOAD LOADING | FCGR2A, FCGR3B, FCGR1A | GABRA1 600/4885GABRG2 1063/4885GABRB3 1396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.